1
|
Liu Y, Zhao Z, Guo J, Ma Y, Li J, Ji H, Chen Z, Zheng J. Anacardic acid improves neurological deficits in traumatic brain injury by anti-ferroptosis and anti-inflammation. Exp Neurol 2023; 370:114568. [PMID: 37820939 DOI: 10.1016/j.expneurol.2023.114568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 09/23/2023] [Accepted: 10/07/2023] [Indexed: 10/13/2023]
Abstract
BACKGROUND Traumatic brain injury (TBI) is an important cause of disability and death. TBI leads to multiple forms of nerve cell death including ferroptosis due to iron-dependent lipid peroxidation. Anacardic acid (AA) is a natural component extracted from cashew nut shells, which has been reported to have neuroprotective effects in traumatic brain injury. We investigated whether AA has an anti-ferroptosis effect in TBI. METHODS We used the Feeney free-fall impact method to construct a TBI model to investigate the effect of AA on ferroptosis caused by TBI, in which Ferrostatin-1 (Fer-1), a ferroptosis inhibitor, served as a positive control group. We first identified the therapeutic effect of AA on TBI through modified neurological severity score (mNSS) and determined the appropriate concentration. Secondly, we investigated the effect of AA on the expression level of the key protein of ferroptosis by Western blotting and immunohistochemistry. Then the effect of AA on nerve tissue injury and nerve function improvement was verified. Finally, enzym-linked immunosorbent assay (ELISA) was used to verify that AA could reduce inflammation after TBI. RESULTS We found the intensely inhibitory effect of AA on ferroptosis, which is in parallel with the results obtained after Fer-1 treatment. In addition, AA and Fer-1 mitigated TBI-mediated tissue defects, destruction of the blood-brain barrier, and neurodegeneration. Novel object recognition (NOR), mNSS and water maze test showed that AA could significantly reduce the impairment of neural function and behavioral cognitive ability caused by TBI. Finally, we also demonstrated that AA has not only an anti-ferroptosis effect, but also an anti-inflammation effect. CONCLUSIONS AA can reduce the neurological impairment and behavioral cognitive impairment caused by TBI through the dual effect of anti-ferroptosis and anti-inflammation.
Collapse
Affiliation(s)
- Yu Liu
- Department of Neurosurgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223022, China; Xuzhou Medical University, Xuzhou 221000, China
| | - Zongren Zhao
- Department of Neurosurgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223022, China
| | - Jianqiang Guo
- Department of Neurosurgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223022, China; Xuzhou Medical University, Xuzhou 221000, China
| | - Yuanhao Ma
- Department of Neurosurgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223022, China; Xuzhou Medical University, Xuzhou 221000, China
| | - Jing Li
- Department of Neurosurgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223022, China
| | - Huanhuan Ji
- Department of Neurosurgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223022, China
| | - Zhongjun Chen
- Department of Neurosurgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223022, China
| | - Jinyu Zheng
- Department of Neurosurgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an 223022, China.
| |
Collapse
|
2
|
kamruzzaman S, Bulbul L, Alam MZ, Rahman MM. GABA content and an antioxidant profile positively correlated with the anticonvulsive activity of Microcos paniculata in acute seizure mice. Heliyon 2023; 9:e18295. [PMID: 37539232 PMCID: PMC10395524 DOI: 10.1016/j.heliyon.2023.e18295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 07/06/2023] [Accepted: 07/13/2023] [Indexed: 08/05/2023] Open
Abstract
This study evaluated the effects of different parts of M. paniculata (MP) extracts on convulsions and antioxidant activities in mice. Six polyphenolic compounds were identified, where epicatechin and quercetin have been identified in the highest amounts (23.01 and 32.23 mg/100 g of dry MP extract, respectively) in MP leaf and stem extracts, using Ultra Performance Liquid Chromatography. 7-day oral administration of MP at doses of 100, 200, and 400 mg/kg body weight (BW) significantly reduced convulsions and reduced mortality rates compared with seizure inducer groups. Antioxidant potentials were measured by superoxide dismutase (SOD), catalase (CAT), thiobarbituric acid reactive substances (TBARS), and reduced glutathione (GSH) content in whole-brain homogenates. Gamma-aminobutyric acid (GABA) levels significantly increased in leaves and stem-treated groups, suggesting that MP leaves and stems have potent antioxidant properties that can attenuate convulsions by modulating the GABAergic system and antioxidant activities.
Collapse
Affiliation(s)
- S.M. kamruzzaman
- Department of Horticulture, Sher-e-Bangla Agricultural University, Dhaka, Bangladesh
| | - Latifa Bulbul
- Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh
| | - Md Zahir Alam
- Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh
| | | |
Collapse
|
3
|
de Oliveira FR, da Silva NM, Hamoy M, Crespo-López ME, Ferreira IM, da Silva EO, de Matos Macchi B, do Nascimento JLM. The GABAergic System and Endocannabinoids in Epilepsy and Seizures: What Can We Expect from Plant Oils? Molecules 2022; 27:molecules27113595. [PMID: 35684543 PMCID: PMC9182121 DOI: 10.3390/molecules27113595] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Revised: 05/27/2022] [Accepted: 05/30/2022] [Indexed: 02/01/2023] Open
Abstract
Seizures and epilepsy are some of the most common serious neurological disorders, with approximately 80% of patients living in developing/underdeveloped countries. However, about one in three patients do not respond to currently available pharmacological treatments, indicating the need for research into new anticonvulsant drugs (ACDs). The GABAergic system is the main inhibitory system of the brain and has a central role in seizures and the screening of new ACD candidates. It has been demonstrated that the action of agents on endocannabinoid receptors modulates the balance between excitatory and inhibitory neurotransmitters; however, studies on the anticonvulsant properties of endocannabinoids from plant oils are relatively scarce. The Amazon region is an important source of plant oils that can be used for the synthesis of new fatty acid amides, which are compounds analogous to endocannabinoids. The synthesis of such compounds represents an important approach for the development of new anticonvulsant therapies.
Collapse
Affiliation(s)
- Fábio Rodrigues de Oliveira
- Programa de Pós-Graduação em Neurociências e Biologia Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil; (F.R.d.O.); (N.M.d.S.); (E.O.d.S.)
- Laboratório de Controle de Qualidade e Bromatologia, Curso de Farmácia, Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá 68902-280, Brazil
| | - Nágila Monteiro da Silva
- Programa de Pós-Graduação em Neurociências e Biologia Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil; (F.R.d.O.); (N.M.d.S.); (E.O.d.S.)
- Laboratório de Neuroquímica Molecular e Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil;
| | - Moisés Hamoy
- Laboratório de Farmacologia e Toxicologia de Produtos Naturais, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil;
- Programa de Pós-Graduação em Farmacologia e Bioquímica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil;
| | - Maria Elena Crespo-López
- Programa de Pós-Graduação em Farmacologia e Bioquímica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil;
- Laboratório de Farmacologia Molecular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil
| | - Irlon Maciel Ferreira
- Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá 68902-280, Brazil;
- Laboratório de Biocatálise e Síntese Orgânica Aplicada, Departamento de Ciências Exatas e Tecnológicas, Universidade Federal do Amapá, Macapá 68902-280, Brazil
| | - Edilene Oliveira da Silva
- Programa de Pós-Graduação em Neurociências e Biologia Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil; (F.R.d.O.); (N.M.d.S.); (E.O.d.S.)
- Laboratorio de Biologia Estrutural, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil
- Instituto Nacional de Ciência e Tecnologia de Biologia Estrutural e Bioimagem (INCT-INBEB), Rio de Janeiro 21941-590, Brazil
| | - Barbarella de Matos Macchi
- Laboratório de Neuroquímica Molecular e Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil;
- Programa de Pós-Graduação em Farmacologia e Bioquímica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil;
| | - José Luiz Martins do Nascimento
- Programa de Pós-Graduação em Neurociências e Biologia Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil; (F.R.d.O.); (N.M.d.S.); (E.O.d.S.)
- Laboratório de Neuroquímica Molecular e Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil;
- Programa de Pós-Graduação em Farmacologia e Bioquímica, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil;
- Programa de Pós-Graduação em Ciências Farmacêuticas, Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá 68902-280, Brazil;
- Instituto Nacional de Ciência e Tecnologia em Neuroimunomodulação (INCT-NIM), Rio de Janeiro 21040-900, Brazil
- Correspondence:
| |
Collapse
|
4
|
Roy A, Fajardie P, Lepoittevin B, Baudoux J, Lapinte V, Caillol S, Briou B. CNSL, a Promising Building Blocks for Sustainable Molecular Design of Surfactants: A Critical Review. Molecules 2022; 27:molecules27041443. [PMID: 35209231 PMCID: PMC8876098 DOI: 10.3390/molecules27041443] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Revised: 02/09/2022] [Accepted: 02/10/2022] [Indexed: 11/16/2022] Open
Abstract
Surfactants are crystallizing a certain focus for consumer interest, and their market is still expected to grow by 4 to 5% each year. Most of the time these surfactants are of petroleum origin and are not often biodegradable. Cashew Nut Shell Liquid (CNSL) is a promising non-edible renewable resource, directly extracted from the shell of the cashew nut. The interesting structure of CNSL and its components (cardanol, anacardic acid and cardol) lead to the synthesis of biobased surfactants. Indeed, non-ionic, anionic, cationic and zwitterionic surfactants based on CNSL have been reported in the literature. Even now, CNSL is absent or barely mentioned in specialized review or chapters talking about synthetic biobased surfactants. Thus, this review focuses on CNSL as a building block for the synthesis of surfactants. In the first part, it describes and criticizes the synthesis of molecules and in the second part, it compares the efficiency and the properties (CMC, surface tension, kraft temperature, biodegradability) of the obtained products with each other and with commercial ones.
Collapse
Affiliation(s)
- Audrey Roy
- Orpia Innovation, CNRS, Bâtiment Chimie Balard, 1919 Route de Mendes, 34000 Montpellier, France;
| | - Pauline Fajardie
- Institut Charles Gerhardt Montpellier (ICGM), Université de Montpellier, CNRS, ENSCM, 34095 Montpellier, France; (P.F.); (V.L.); (S.C.)
| | - Bénédicte Lepoittevin
- Laboratoire de Chimie Moléculaire et Thio-Organique (LCMT), Normandie Université, ENSICAEN, UNICAEN, UMR CNRS 6507, 6 Boulevard Maréchal Juin, 14050 Caen, France; (B.L.); (J.B.)
| | - Jérôme Baudoux
- Laboratoire de Chimie Moléculaire et Thio-Organique (LCMT), Normandie Université, ENSICAEN, UNICAEN, UMR CNRS 6507, 6 Boulevard Maréchal Juin, 14050 Caen, France; (B.L.); (J.B.)
| | - Vincent Lapinte
- Institut Charles Gerhardt Montpellier (ICGM), Université de Montpellier, CNRS, ENSCM, 34095 Montpellier, France; (P.F.); (V.L.); (S.C.)
| | - Sylvain Caillol
- Institut Charles Gerhardt Montpellier (ICGM), Université de Montpellier, CNRS, ENSCM, 34095 Montpellier, France; (P.F.); (V.L.); (S.C.)
| | - Benoit Briou
- Orpia Innovation, CNRS, Bâtiment Chimie Balard, 1919 Route de Mendes, 34000 Montpellier, France;
- Correspondence: ; Tel.: +33-6-32-83-21-76
| |
Collapse
|
5
|
Vogt AG, de Oliveira RL, Voss GT, Blödorn GB, Alves D, Wilhelm EA, Luchese C. QCTA-1, a quinoline derivative, ameliorates pentylenetetrazole-induced kindling and memory comorbidity in mice: Involvement of antioxidant system of brain. Pharmacol Biochem Behav 2022; 215:173357. [DOI: 10.1016/j.pbb.2022.173357] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/09/2021] [Revised: 02/10/2022] [Accepted: 02/16/2022] [Indexed: 01/19/2023]
|
6
|
Li E, Wang Y, Li Q, Li L, Wei L. Protective Effects of Sal B on Oxidative Stress-Induced Aging by Regulating the Keap1/Nrf2 Signaling Pathway in Zebrafish. Molecules 2021; 26:5239. [PMID: 34500674 PMCID: PMC8434535 DOI: 10.3390/molecules26175239] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 08/24/2021] [Accepted: 08/27/2021] [Indexed: 12/12/2022] Open
Abstract
The models of oxidative damage-induced aging were established by adding ethanol (C2H5OH), hydrogen peroxide (H2O2) and 6-hydroxydopamine (6-OHDA) to zebrafish embryos in this research. To find effective protective drugs/foods, Salvianolic acid B (Sal B) was added after the embryos were treated by these oxidative reagents. After being treated with ethanol, H2O2 and 6-OHDA, the morphological changes were obvious and the deformities included spinal curvature, heart bleeding, liver bleeding, yolk sac deformity and pericardial edema, and the expression of oxidative stress-related genes Nrf2b, sod1 and sod2 and aging-related genes myl2a and selenbp1 were significantly up-regulated compared to the control group. While after adding 0.05 μg/mL and 0.5 μg/mL Sal B to the ethanol-treated group, death rates and MDA levels decreased, the activity of antioxidant enzyme (SOD, CAT and GSH-Px) changed and Nrf2b, sod1, sod2, myl2a, selenbp1, p53 and p21 were down-regulated compared to the ethanol-treated group. The bioinformatics analysis also showed that oxidative stress-related factors were associated with a variety of cellular functions and physiological pathways. In conclusion, Sal B can protect against aging through regulating the Keap1/Nrf2 pathway as well as antioxidative genes and enzyme activity.
Collapse
Affiliation(s)
- Erzhuo Li
- State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin 150090, China;
- School of Life Science and Technology, Harbin Instituted of Technology, Harbin 150001, China; (Y.W.); (Q.L.)
| | - Yunhao Wang
- School of Life Science and Technology, Harbin Instituted of Technology, Harbin 150001, China; (Y.W.); (Q.L.)
| | - Qiao Li
- School of Life Science and Technology, Harbin Instituted of Technology, Harbin 150001, China; (Y.W.); (Q.L.)
| | - Li Li
- School of Life Science and Technology, Harbin Instituted of Technology, Harbin 150001, China; (Y.W.); (Q.L.)
| | - Lijun Wei
- State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin 150090, China;
- School of Life Science and Technology, Harbin Instituted of Technology, Harbin 150001, China; (Y.W.); (Q.L.)
| |
Collapse
|
7
|
Jamshidi S, Moradi Y, Nameni G, Mohsenpour MA, Vafa M. Effects of cashew nut consumption on body composition and glycemic indices: A meta-analysis and systematic review of randomized controlled trials. Diabetes Metab Syndr 2021; 15:605-613. [PMID: 33725628 DOI: 10.1016/j.dsx.2021.02.038] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 02/24/2021] [Accepted: 02/26/2021] [Indexed: 02/07/2023]
Abstract
BACKGROUND AND AIMS Present meta-analysis and systematic review was conducted to synthesis a definitive conclusion from previous randomized controlled clinical trials (RCTs). METHODS A comprehensive search was done up to July 2020, in order to extract RCTs which investigated the effect of cashew nut on weight, body mass index (BMI), waist circumference (WC), fasting blood sugar (FBS), insulin, and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR). Weighted mean difference (WMD) and 95% confidence interval (CI) were used to estimate effect size. Meta regression analysis was done to identify probable sources of heterogeneity. RESULTS Six clinical trials with 521 participants were included. Combined effect sizes demonstrated no effect of cashew consumption on weight (WMD): 0.02, 95% CI: -1.04, 1.09, P > 0.05), BMI (WMD: 0.1, 95% CI: -0.72, 0.74, P > 0.05), and WC (WMD: -0.13, 95% CI: -1.97, 1.70, P > 0.05). Results were also not significant for FBS (WMD: 3.58, 95% CI: -3.92, 11.08, P > 0.05), insulin (WMD: -0.19, 95% CI: -1.63, 1.25, P > 0.05), and HOMA-IR (WMD: 0.25, 95% CI: -0.55, 1.06, P > 0.05). CONCLUSION The sum up, incorporating cashew into the diet has no significant effect on body composition or modifying glycemic indices.
Collapse
Affiliation(s)
- Sanaz Jamshidi
- Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
| | - Yousef Moradi
- Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
| | - Ghazaleh Nameni
- Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
| | - Mohammad Ali Mohsenpour
- Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mohammadreza Vafa
- Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
| |
Collapse
|
8
|
Gong G, Chen H, Kam H, Chan G, Tang YX, Wu M, Tan H, Tse YC, Xu HX, Lee SMY. In Vivo Screening of Xanthones from Garcinia oligantha Identified Oliganthin H as a Novel Natural Inhibitor of Convulsions. JOURNAL OF NATURAL PRODUCTS 2020; 83:3706-3716. [PMID: 33296199 DOI: 10.1021/acs.jnatprod.0c00963] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Epilepsy is a chronic neurological disorder, characterized by recurrent, spontaneous, and transient seizures, and affects more than 70 million people worldwide. Although two dozen antiepileptic drugs (AEDs) are approved and available in the market, seizures remain poorly controlled in one-third of epileptic patients who are suffering from drug resistance or various adverse effects. Recently, the xanthone skeleton has been regarded as an attractive scaffold for the discovery and development of emerging anticonvulsants. We had isolated several dihydroxanthone derivatives previously, including oliganthin H, oliganthin I, and oliganthin N, whose structures were similar and delicately elucidated by spectrum analysis or X-ray crystallographic data, from extracts of leaves of Garcinia oligantha. These xanthone analogues were evaluated for anticonvulsant activity, and a novel xanthone, oliganthin H, has been identified as a sound and effective natural inhibitor of convulsions in zebrafish in vivo. A preliminary structure-activity relationship analysis on the relationship between structures of the xanthone analogues and their activities was also conducted. Oliganthin H significantly suppressed convulsant behavior and reduced to about 25% and 50% of PTZ-induced activity, in 12.5 and 25 μM treatment groups (P < 0.01 and 0.001), respectively. Meanwhile, it reduced seizure activity, velocity, seizure duration, and number of bursts in zebrafish larvae (P < 0.05). Pretreatment of oliganthin H significantly restored aberrant induction of gene expressions including npas4a, c-fos, pyya, and bdnf, as well as gabra1, gad1, glsa, and glula, upon PTZ treatment. In addition, in silico analysis revealed the stability of the oliganthin H-GABAA receptor complex and their detailed binding pattern. Therefore, direct interactions with the GABAA receptor and involvement of downstream GABA-glutamate pathways were possible mechanisms of the anticonvulsant action of oliganthin H. Our findings present the anticonvulsant activity of oliganthin H, provide a novel scaffold for further modifications, and highlight the xanthone skeleton as an attractive and reliable resource for the development of emerging AEDs.
Collapse
Affiliation(s)
- Guiyi Gong
- State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau, China
- The Second Affiliated Hospital, Southern University of Science and Technology (SUSTech), Shenzhen, 518055, China
| | - Hanbin Chen
- State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau, China
| | - Hiotong Kam
- State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau, China
| | - Ging Chan
- State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau, China
| | - Yue-Xun Tang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
| | - Man Wu
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
| | - Hongsheng Tan
- Clinical Research Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200240, China
| | - Yu-Chung Tse
- Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Department of Biology, Southern University of Science and Technology (SUSTech), Shenzhen, 518055, China
| | - Hong-Xi Xu
- Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
| | - Simon Ming-Yuen Lee
- State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau, China
| |
Collapse
|
9
|
Hou L, Rashid M, Chhabra M, Chandrasekhar B, Amirthalingam P, Ray S, Li Z. The effect of Bertholletia excelsa on body weight, cholestrol, and c-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 2020; 57:102636. [PMID: 33271300 DOI: 10.1016/j.ctim.2020.102636] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2020] [Revised: 11/23/2020] [Accepted: 11/24/2020] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND & OBJECTIVE(S) Bertholletia excelsa is a rich herbal source of anti-oxidants and phenols. The goal of this study is to evaluation the effect of bertholletia excelsa nut on body weight, C-reactive protein (CRP) and lipid profile. METHODS A literature search was conducted in PubMed, Scopus and Web of sciences databases by two reviewers up to October 2019. Random effect model used to combine results. RESULTS Six studies included in analysis with 71 participants. The population was public population. Pooled results showed Bertholletia excelsa have reduction effect on triglyceride weighted mean difference (WMD: -8.23 mg/dl, 95 % CI -15.09, -1.38, I² = 0%), Cholesterol (WMD: -14.31 mg/dl, 95 % CI -23.38, -5.24, I² = 47 %), Low-density lipoprotein (LDL) (WMD: -9.27 mg/dl, 95 % CI -13.48, -5.06, I² = 0%). CONCLUSION This study provided an evidence that Bertholletia excelsa nuts have reduction effect on triglyceride, cholesterol, and LDL levels.
Collapse
Affiliation(s)
- Lili Hou
- Department of Clinical Nutrition, Taizhou People's Hospital, Taizhou, Jiangsu, 225300, China
| | - Muhammed Rashid
- Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, BG Nagar, 571448, Karnataka, India
| | - Manik Chhabra
- Department of Pharmacy Practice, Indo-Soviet Friendship College of Pharmacy, Moga, 142001, Punjab, India
| | - Boya Chandrasekhar
- Creative Educational Society's College of Pharmacy, Andra Pradesh, India
| | | | - Sujoy Ray
- Department of Psychiatry, St. John's Medical College and Hospital, Bangalore, India
| | - Zhenzuo Li
- Department of Endocrinology, The Fourth people's Hospital of Jinan City, No.50 Normal Road, Tianqiao District, Jinan, Shandong Province, 250031, China.
| |
Collapse
|
10
|
Vieira DFF, Junior ALG, Machado KDC, Maia WMN, Nascimento TLD, Rios MADS, Lopes LDS. Evaluation of the anticonvulsant and antioxidant activity of alkylated cardanol in rodents. Nat Prod Res 2020; 35:6168-6174. [PMID: 33143464 DOI: 10.1080/14786419.2020.1831496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
The present study aims to evaluate the anticonvulsant and antioxidant activity of the alkylated cardanol in mice, as well as the possible mechanisms involved. Albino mice were used. The pentylenetetrazol, picrotoxin, and pilocarpine were used to induce seizures clonic. The effect of selective receptor antagonist GABAA on anticonvulsant activity was investigated with flumazenil. The antioxidant activity was evaluated by the formation of lipid peroxides, nitrite content, and concentration of reduced glutathione. The largest dose of alkylated cardanol increased the latency of the first seizure induced by pentylenetetrazol acting on the GABAergic receptors. The treatment did not alter body weight and did not cause death in animals. It was observed a reduction in locomotor activity and motor coordination. Treatment reduced the level of lipid peroxidation and contents of nitrite and increased levels of GSH in the hippocampus and frontal cortex. Alkylated cardanol showed a protective effect against convulsions induced in mice.
Collapse
Affiliation(s)
- Danielle Fernanda Fernandes Vieira
- Postgraduate Programs in Pharmaceutical Sciences and Laboratory of Research in Experimental Neurochemistry (LAPNEX), Federal University of Piauí, Teresina, Brazil
| | - Antonio Luiz Gomes Junior
- Postgraduate Programs in Pharmaceutical Sciences and Biotechnology, Federal University of Piauí, Teresina, Brazil
| | - Keylla da Conceição Machado
- Postgraduate Programs in Pharmaceutical Sciences and Laboratory of Research in Experimental Neurochemistry (LAPNEX), Federal University of Piauí, Teresina, Brazil
| | - Wcleubianne Matias Nascimento Maia
- Postgraduate Programs in Pharmaceutical Sciences and Laboratory of Research in Experimental Neurochemistry (LAPNEX), Federal University of Piauí, Teresina, Brazil
| | - Tassio Lessa do Nascimento
- Instituto Federal de Educação Ciência e Tecnologia, Campus Tabuleiro do Norte, Sítio Taperinha, Tabuleiro do Norte, CE, Brazil
| | - Maria Alexsandra de Sousa Rios
- Departamento de Engenharia Mecânica Grupo de Inovações Tecnológicas e Especialidades Químicas Campus do Pici, Universidade Federal do Ceará, Fortaleza, CE, Brazil
| | - Luciano da Silva Lopes
- Department of Biophysics and Physiology, Programs in Pharmaceutical Sciences, Laboratory of Research in Experimental Neurochemistry [LAPNEX], Federal University of Piauí, Teresina, Brazil
| |
Collapse
|
11
|
Gomes Júnior A, Islam MT, Nicolau LAD, de Souza LKM, Araújo TDS, Lopes de Oliveira GA, de Melo Nogueira K, da Silva Lopes L, Medeiros JVR, Mubarak MS, Melo-Cavalcante AAC. Anti-Inflammatory, Antinociceptive, and Antioxidant Properties of Anacardic Acid in Experimental Models. ACS OMEGA 2020; 5:19506-19515. [PMID: 32803044 PMCID: PMC7424580 DOI: 10.1021/acsomega.0c01775] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Accepted: 07/09/2020] [Indexed: 06/11/2023]
Abstract
Anacardic acid (AA), a compound extracted from cashew nut liquid, exhibits numerous pharmacological activities. The aim of the current investigation was to assess the anti-inflammatory, antinociceptive, and antioxidant activities of AA in mouse models. For this, Swiss albino mice were pretreated with AA (10, 25, 50 mg/kg, intraperitoneally, ip) 30 min prior to the administration of carrageenan, as well as 25 mg/kg of prostaglandin E2, dextran, histamine, and compound 48/80. The antinociceptive activity was evaluated by formalin, abdominal, and hot plate tests, using antagonist of opioid receptors (naloxene, 3 mg/kg, ip) to identify antinociceptive mechanisms. Results from this study revealed that AA at 25 mg/kg inhibits carrageenan-induced edema. In addition, AA at 25 mg/kg reduced edema and leukocyte and neutrophilic migration to the intraperitoneal cavity, diminished myeloperoxidase activity and malondialdehyde concentration, and increased the levels of reduced glutathione. In nociceptive tests, it also decreased licking, abdominal writhing, and latency to thermal stimulation, possibly via interaction with opioid receptors. Taken together, these results indicate that AA exhibits anti-inflammatory and antinociceptive actions and also reduces oxidative stress in acute experimental models, suggesting AA as a promising compound in the pharmaceutical arena.
Collapse
Affiliation(s)
- Antonio
Luiz Gomes Júnior
- RENORBIO
- Post-Graduation Program in Biotechnology, Federal University of Piauí, Teresina 64049-550, Piauí, Brazil
- LAPNEX
- Laboratory of Research in Experimental Neurochemistry of Post-Graduation
Program in Pharmaceutical Sciences, Federal
University of Piauí, Teresina CEP 64049-550, Piauí, Brazil
- LAPGENIC
- Laboratory of Research in Genetic Toxicology of Post-Graduation
Program in Pharmaceutical Sciences, Federal
University of Piauí, Teresina 64049-550, Piauí, Brazil
| | - Muhammad Torequl Islam
- Laboratory
of Theoretical and Computational Biophysics, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam
- Faculty
of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam
| | - Lucas Antonio Duarte Nicolau
- LAFFEX -
Laboratory of Experimental Physiopharmacology in Biotechnology and
Biodiversity Center Research (BIOTEC), Federal
University of Piauí-CMRV, Parnaíba 64202-020, Piauí, Brazil
| | - Luan Kevin Miranda de Souza
- RENORBIO
- Post-Graduation Program in Biotechnology, Federal University of Piauí, Teresina 64049-550, Piauí, Brazil
- LAFFEX -
Laboratory of Experimental Physiopharmacology in Biotechnology and
Biodiversity Center Research (BIOTEC), Federal
University of Piauí-CMRV, Parnaíba 64202-020, Piauí, Brazil
| | - Tiago de Souza
Lopes Araújo
- RENORBIO
- Post-Graduation Program in Biotechnology, Federal University of Piauí, Teresina 64049-550, Piauí, Brazil
- LAFFEX -
Laboratory of Experimental Physiopharmacology in Biotechnology and
Biodiversity Center Research (BIOTEC), Federal
University of Piauí-CMRV, Parnaíba 64202-020, Piauí, Brazil
| | - Guilherme Antônio Lopes de Oliveira
- RENORBIO
- Post-Graduation Program in Biotechnology, Federal University of Piauí, Teresina 64049-550, Piauí, Brazil
- LAPNEX
- Laboratory of Research in Experimental Neurochemistry of Post-Graduation
Program in Pharmaceutical Sciences, Federal
University of Piauí, Teresina CEP 64049-550, Piauí, Brazil
- LAFFEX -
Laboratory of Experimental Physiopharmacology in Biotechnology and
Biodiversity Center Research (BIOTEC), Federal
University of Piauí-CMRV, Parnaíba 64202-020, Piauí, Brazil
| | - Kerolayne de Melo Nogueira
- LAFFEX -
Laboratory of Experimental Physiopharmacology in Biotechnology and
Biodiversity Center Research (BIOTEC), Federal
University of Piauí-CMRV, Parnaíba 64202-020, Piauí, Brazil
| | - Luciano da Silva Lopes
- LAPNEX
- Laboratory of Research in Experimental Neurochemistry of Post-Graduation
Program in Pharmaceutical Sciences, Federal
University of Piauí, Teresina CEP 64049-550, Piauí, Brazil
| | - Jand-Venes Rolim Medeiros
- RENORBIO
- Post-Graduation Program in Biotechnology, Federal University of Piauí, Teresina 64049-550, Piauí, Brazil
- LAFFEX -
Laboratory of Experimental Physiopharmacology in Biotechnology and
Biodiversity Center Research (BIOTEC), Federal
University of Piauí-CMRV, Parnaíba 64202-020, Piauí, Brazil
| | | | - Ana Amélia
de Carvalho Melo-Cavalcante
- RENORBIO
- Post-Graduation Program in Biotechnology, Federal University of Piauí, Teresina 64049-550, Piauí, Brazil
- LAPGENIC
- Laboratory of Research in Genetic Toxicology of Post-Graduation
Program in Pharmaceutical Sciences, Federal
University of Piauí, Teresina 64049-550, Piauí, Brazil
| |
Collapse
|
12
|
Augusto RL, Mendonça IP, de Albuquerque Rego GN, Pereira DD, da Penha Gonçalves LV, Dos Santos ML, de Souza RF, Moreno GMM, Cardoso PRG, de Souza Andrade D, da Silva-Júnior JC, Pereira MC, Peixoto CA, Medeiros-Linard CFB, de Souza IA, Andrade-da-Costa BLDS. Purified anacardic acids exert multiple neuroprotective effects in pesticide model of Parkinson's disease: in vivo and in silico analysis. IUBMB Life 2020; 72:1765-1779. [PMID: 32449271 DOI: 10.1002/iub.2304] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Revised: 04/22/2020] [Accepted: 04/23/2020] [Indexed: 11/08/2022]
Abstract
Parkinson's disease (PD) induced by environmental toxins involves a multifactorial cascade of harmful factors, thus motivating the search for therapeutic agents able to act on the greatest number of molecular targets. This study evaluated the efficacy of 50 mg/kg purified anacardic acids (AAs), isolated from cashew nut shell liquid, on multiple steps of oxidative stress and inflammation induced by rotenone in the substantia nigra (SN) and striatum. Adult mice were divided into four groups: Control, rotenone, AAs + rotenone, and AAs alone. Lipoperoxidation, nitric oxide (NO) levels, and reduced glutathione (GSH)/oxidized gluthatione (GSSG) ratio were evaluated. NF-kB-p65, pro-IL-1β, cleaved IL-1β, metalloproteinase-9, Tissue Inhibitory Factor-1 (TIMP-1), tyrosine hydroxylase (TH), and glial fibrillary acidic protein (GFAP) levels were assessed by Western blot. In silico studies were also made using the SwissADME web tool. Rotenone increased lipoperoxidation and NO production and reduced TH levels and GSH/GSSG ratio in both SN and striatum. It also enhanced NF-kB-p65, pro, and cleaved IL-1β, MMP-9, GFAP levels compared to control and AAs groups. The AAs alone reduced pro-IL-1β in the striatum while they augmented TIMP1 and reduced MMP-9 amounts in both regions. AAs reversed rotenone-induced effects on lipoperoxidation, NO production, and GSH/GSSG ratio, as well as increased TH and attenuated pro-IL-1β and MMP-9 levels in both regions, NF-kB-p65 in the SN and GFAP in the striatum. Altogether, the in vivo and in silico analysis reinforced multiple and defined molecular targets of AAs, identifying that they are promising neuroprotective drug candidates for PD, acting against oxidative and inflammatory conditions induced by rotenone.
Collapse
Affiliation(s)
- Ricielle L Augusto
- Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, UFPE, Recife, Brazil
| | - Ingrid P Mendonça
- Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, UFPE, Recife, Brazil.,Departamento de Entomologia, Laboratório de Ultraestrutura, Instituto Aggeu Magalhães-FIOCRUZ, Recife, Brazil.,Instituto Nacional de Ciência e Tecnologia de Neuroimunomodulação (NIM), Rio de Janeiro, Brazil
| | | | - Danielle D Pereira
- Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, UFPE, Recife, Brazil
| | | | - Maria L Dos Santos
- Instituto de Química, Divisão de Química orgânica, Universidade de Brasília, UnB, Brasilia, Brazil
| | - Raphael F de Souza
- Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, UFPE, Recife, Brazil.,Departamento de Educação Física, Universidade Federal de Sergipe, UFS, São Cristóvam, Brazil
| | - Giselle M M Moreno
- Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, UFPE, Recife, Brazil
| | - Pablo R G Cardoso
- Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, UFPE, Recife, Brazil
| | - Daniele de Souza Andrade
- Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, UFPE, Recife, Brazil
| | - José C da Silva-Júnior
- Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, UFPE, Recife, Brazil
| | - Michelly C Pereira
- Departamento de Fisiologia e Farmacologia, Universidade Federal de Pernambuco, UFPE, Recife, Brazil
| | - Christina A Peixoto
- Departamento de Entomologia, Laboratório de Ultraestrutura, Instituto Aggeu Magalhães-FIOCRUZ, Recife, Brazil.,Instituto Nacional de Ciência e Tecnologia de Neuroimunomodulação (NIM), Rio de Janeiro, Brazil
| | | | - Ivone A de Souza
- Departamento de Antibióticos, Universidade Federal de Pernambuco, Recife, Brazil
| | | |
Collapse
|
13
|
Deng H, Fujiwara N, Cui H, Whitford GM, Bartlett JD, Suzuki M. Histone acetyltransferase promotes fluoride toxicity in LS8 cells. CHEMOSPHERE 2020; 247:125825. [PMID: 31927229 PMCID: PMC7863547 DOI: 10.1016/j.chemosphere.2020.125825] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/09/2019] [Revised: 12/31/2019] [Accepted: 01/02/2020] [Indexed: 05/30/2023]
Abstract
Previously we demonstrated that fluoride increased acetylated-p53 (Ac-p53) in LS8 cells that are derived from mouse enamel organ epithelia and in rodent ameloblasts. However, how p53 is acetylated by fluoride and how the p53 upstream molecular pathway responds to fluoride is not well characterized. Here we demonstrate that fluoride activates histone acetyltransferases (HATs) including CBP, p300, PCAF and Tip60 to acetylate p53. HAT activity is regulated by post-translational modifications such as acetylation and phosphorylation. HAT proteins and their post-translational modifications (p300, Acetyl-p300, CBP, Acetyl-CBP, Tip60 and phospho-Tip60) were analyzed by Western blots. p53-HAT binding was detected by co-immunoprecipitation (co-IP). Cell growth inhibition was analyzed by MTT assays. LS8 cells were treated with NaF with/without HAT inhibitors MG149 (Tip60 inhibitor) and Anacardic Acid (AA; inhibits p300/CBP and PCAF). MG149 or AA was added 1 h prior to NaF treatment. Co-IP results showed that NaF increased p53-CBP binding and p53-PCAF binding. NaF increased active Acetyl-p300, Acetyl-CBP and phospho-Tip60 levels, suggesting that fluoride activates these HATs. Fluoride-induced phospho-Tip60 was decreased by MG149. MG149 or AA treatment reversed fluoride-induced cell growth inhibition at 24 h. MG149 or AA treatment decreased fluoride-induced p53 acetylation to inhibit caspase-3 cleavage, DNA damage marker γH2AX expression and cytochrome-c release into the cytosol. These results suggest that acetylation of p53 by HATs contributes, at least in part, to fluoride-induced toxicity in LS8 cells via cell growth inhibition, apoptosis, DNA damage and mitochondrial damage. Modulation of HAT activity may, therefore, be a potential therapeutic target to mitigate fluoride toxicity in ameloblasts.
Collapse
Affiliation(s)
- Huidan Deng
- College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu, Sichuan, 611130, China.
| | - Natsumi Fujiwara
- Department of Oral Biology and Diagnostic Sciences, The Dental College of Georgia, Augusta University, Augusta, GA, 30912, USA.
| | - Hengmin Cui
- College of Veterinary Medicine, Sichuan Agricultural University, Wenjiang, Chengdu, Sichuan, 611130, China.
| | - Gary M Whitford
- Department of Oral Biology and Diagnostic Sciences, The Dental College of Georgia, Augusta University, Augusta, GA, 30912, USA.
| | - John D Bartlett
- Division of Biosciences, College of Dentistry, The Ohio State University, Columbus, OH, 43210, USA.
| | - Maiko Suzuki
- Department of Oral Biology and Diagnostic Sciences, The Dental College of Georgia, Augusta University, Augusta, GA, 30912, USA.
| |
Collapse
|
14
|
Rodrigues de Oliveira F, Eleuterio Rodrigues K, Hamoy M, Rodrigues Sarquis Í, Otake Hamoy A, Elena Crespo Lopez M, Maciel Ferreira I, de Matos Macchi B, Luiz Martins do Nascimento J. Fatty Acid Amides Synthesized from Andiroba Oil ( Carapa guianensis Aublet.) Exhibit Anticonvulsant Action with Modulation on GABA-A Receptor in Mice: A Putative Therapeutic Option. Pharmaceuticals (Basel) 2020; 13:ph13030043. [PMID: 32164340 PMCID: PMC7151664 DOI: 10.3390/ph13030043] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2020] [Revised: 02/12/2020] [Accepted: 02/19/2020] [Indexed: 12/17/2022] Open
Abstract
Epilepsy is a chronic neurological disease characterized by excessive neuronal activity leading to seizure; about 30% of affected patients suffer from the refractory and pharmacoresistant form of the disease. The anticonvulsant drugs currently used for seizure control are associated with adverse reactions, making it important to search for more effective drugs with fewer adverse reactions. There is increasing evidence that endocannabinoids can pharmacologically modulate action against seizure and antiepileptic disorders. Therefore, the objective of this study is to investigate the anticonvulsant effects of fatty acid amides (FAAs) in a pentylenetetrazole (PTZ)-induced seizure model in mice. FAAs (FAA1 and FAA2) are obtained from Carapa guianensis oil by biocatalysis and are characterized by Fourier Transform Infrared Analysis (FT-IR) and Gas Chromatography-Mass Spectrometry (GC-MS). Only FAA1 is effective in controlling the increased latency time of the first myoclonic jerk and in significantly decreasing the total duration of tonic-clonic seizures relative to the pentylenetetrazol model. Also, electrocortical alterations produced by pentylenetetrazol are reduced when treated by FAA1 that subsequently decreased wave amplitude and energy in Beta rhythm. The anticonvulsant effects of FAA1 are reversed by flumazenil, a benzodiazepine antagonist on Gamma-Aminobutyric Acid-A (GABA-A) receptors, indicating a mode of action via the benzodiazepine site of these receptors. To conclude, the FAA obtained from C. guianensis oil is promising against PTZ-induced seizures.
Collapse
Affiliation(s)
- Fábio Rodrigues de Oliveira
- Programa de Pós graduação em Neurociências e Biologia Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil; (F.R.d.O.)
- Laboratório de Neuroquímica Molecular e Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil
- Laboratório de Controle de Qualidade e Bromatologia, Curso de Farmácia, Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá 68902-280, Brazil
| | - Keuri Eleuterio Rodrigues
- Programa de Pós graduação em Neurociências e Biologia Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil; (F.R.d.O.)
- Laboratório de Neuroquímica Molecular e Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil
| | - Moisés Hamoy
- Laboratório de Farmacologia e Toxicologia de Produtos Naturais, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil
| | - Ícaro Rodrigues Sarquis
- Laboratório de Biocatálise e Síntese Orgânica Aplicada, Departamento de Ciências Exatas e Tecnológicas, Universidade Federal do Amapá, Macapá 68902-280, Brazil
- Programa de Pós graduação em Ciências Farmacêuticas, Departamento de Ciências Biológicas e da saúde, Universidade Federal do Amapá, Macapá 68902-280, Brazil
| | - Akira Otake Hamoy
- Laboratório de Farmacologia e Toxicologia de Produtos Naturais, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil
| | - Maria Elena Crespo Lopez
- Programa de Pós graduação em Neurociências e Biologia Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil; (F.R.d.O.)
- Laboratório de Farmacologia Molecular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil
| | - Irlon Maciel Ferreira
- Laboratório de Biocatálise e Síntese Orgânica Aplicada, Departamento de Ciências Exatas e Tecnológicas, Universidade Federal do Amapá, Macapá 68902-280, Brazil
- Programa de Pós graduação em Ciências Farmacêuticas, Departamento de Ciências Biológicas e da saúde, Universidade Federal do Amapá, Macapá 68902-280, Brazil
| | - Barbarella de Matos Macchi
- Laboratório de Neuroquímica Molecular e Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil
| | - José Luiz Martins do Nascimento
- Programa de Pós graduação em Neurociências e Biologia Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil; (F.R.d.O.)
- Laboratório de Neuroquímica Molecular e Celular, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil
- Programa de Pós graduação em Ciências Farmacêuticas, Departamento de Ciências Biológicas e da saúde, Universidade Federal do Amapá, Macapá 68902-280, Brazil
- Instituto Nacional de Ciência e Tecnologia em Neuroimunomodulação (INCT-NIM), Rio de Janeiro, RJ 21040-900, Brazil
- Correspondence: or
| |
Collapse
|
15
|
Dobrică EC, Găman MA, Cozma MA, Bratu OG, Pantea Stoian A, Diaconu CC. Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department. ACTA ACUST UNITED AC 2019; 55:medicina55080436. [PMID: 31382651 PMCID: PMC6723949 DOI: 10.3390/medicina55080436] [Citation(s) in RCA: 53] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2019] [Revised: 07/20/2019] [Accepted: 07/31/2019] [Indexed: 12/17/2022]
Abstract
BACKGROUND AND OBJECTIVES Polypharmacy heavily impacts the quality of life of patients worldwide. It is a necessary evil in many disorders, and especially in type 2 diabetes mellitus, as patients require treatment both for this condition and its related or unrelated comorbidities. Thus, we aimed to evaluate the use of polypharmacy in type 2 diabetes mellitus vs. non-diabetes patients. MATERIALS AND METHODS A cross-sectional retrospective observational study was conducted. We collected the medical records of patients hospitalized in the Internal Medicine Clinic of the Clinical Emergency Hospital of Bucharest, Romania, for a period of two months (01/01/2018-28/02/2018). Patients diagnosed with type 2 diabetes mellitus were included in the study group, whereas patients who were not diabetic were used as controls. RESULTS The study group consisted of 63 patients with type 2 diabetes mellitus (mean age 69.19 ± 9.67 years, range 46-89 years; 52.38% males). The control group included 63 non-diabetes patients (mean age 67.05 ± 14.40 years, range 42-93 years, 39.68% males). Diabetic patients had more comorbidities (10.35 ± 3.09 vs. 7.48 ± 3.59, p = 0.0001) and received more drugs (7.81 ± 2.23 vs. 5.33 ± 2.63, p = 0.0001) vs. non-diabetic counterparts. The mean number of drug-drug and food-drug interactions was higher in type 2 diabetes mellitus patients vs. controls: 8.86 ± 5.76 vs. 4.98 ± 5.04, p = 0.0003 (minor: 1.22 ± 1.42 vs. 1.27 ± 1.89; moderate: 7.08 ± 4.08 vs. 3.54 ± 3.77; major: 0.56 ± 0.74 vs. 0.37 ± 0.77) and 2.63 ± 1.08 vs. 2.19 ± 1.42 (p = 0.0457), respectively. CONCLUSIONS Polypharmacy should be an area of serious concern also in type 2 diabetes mellitus, especially in the elderly. In our study, type 2 diabetes mellitus patients received more drugs than their non-diabetes counterparts and were exposed to more drug-drug and food-drug interactions.
Collapse
Affiliation(s)
- Elena-Codruța Dobrică
- "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Boulevard, Bucharest 050474, Romania
| | - Mihnea-Alexandru Găman
- "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Boulevard, Bucharest 050474, Romania.
| | - Matei-Alexandru Cozma
- "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Boulevard, Bucharest 050474, Romania
| | - Ovidiu Gabriel Bratu
- "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Boulevard, Bucharest 050474, Romania
- Emergency University Central Military Hospital, 88 Mircea Vulcanescu Street, Bucharest 010825, Romania
- Academy of Romanian Scientists, 54 Splaiul Independentei Street, Bucharest 030167, Romania
| | - Anca Pantea Stoian
- "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Boulevard, Bucharest 050474, Romania
| | - Camelia Cristina Diaconu
- "Carol Davila" University of Medicine and Pharmacy, 8 Eroii Sanitari Boulevard, Bucharest 050474, Romania
- Internal Medicine Clinic, Clinical Emergency Hospital of Bucharest, 8 Calea Floreasca Street, Bucharest 014461, Romania
| |
Collapse
|
16
|
Júnior ALG, Tchekalarova JD, Conceição Machado K, Silva SWC, Paz MFCJ, Nogueira TR, Matos Monteiro Lira BS, Zihad SNK, Islam MT, Ali ES, Sousa Rios MA, Carvalho ALM, Silva Lopes L, Saha SK, Mubarak MS, Carvalho Melo‐Cavalcante AA. Antidepressant‐like effect of anacardic acid in mice via the L‐arginine–nitric oxide–serotonergic system. Phytother Res 2019; 33:2126-2138. [DOI: 10.1002/ptr.6407] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2018] [Revised: 05/01/2019] [Accepted: 05/18/2019] [Indexed: 11/09/2022]
Affiliation(s)
- Antonio Luiz Gomes Júnior
- Laboratório de Pesquisa em Neuroquímica Experimental do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
- Laboratório de Toxicidade Genética do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
- Programa de Pós‐Graduação em Biotecnologia (RENORBIO)Universidade Federal do Piauí Teresina Brazil
| | | | - Keylla Conceição Machado
- Laboratório de Pesquisa em Neuroquímica Experimental do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
- Laboratório de Toxicidade Genética do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
- Programa de Pós‐Graduação em Biotecnologia (RENORBIO)Universidade Federal do Piauí Teresina Brazil
| | - Samara Wanessa Cardoso Silva
- Laboratório de Pesquisa em Neuroquímica Experimental do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
- Laboratório de Toxicidade Genética do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
| | | | - Tiago Rocha Nogueira
- Grupo de Inovação Tecnológicas e Especialidades Químicas (GRINTEQUI)Universidade Federal do Ceará Fortaleza Brazil
| | - Beatriz Santiago Matos Monteiro Lira
- Laboratório de Pesquisa em Neuroquímica Experimental do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
- Laboratório de Toxicidade Genética do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
| | | | - Muhammad Torequl Islam
- Department for Management of Science and Technology DevelopmentTon Duc Thang University Ho Chi Minh City Vietnam
- Faculty of PharmacyTon Duc Thang University Ho Chi Minh City Vietnam
| | - Eunus S. Ali
- Gaco Pharmaceuticals Limited, Dhaka‐1000, Bangladesh, and College of Medicine and Public HealthFlinders University Adelaide South Australia Australia
| | - Maria Alexsandra Sousa Rios
- Grupo de Inovação Tecnológicas e Especialidades Químicas (GRINTEQUI)Universidade Federal do Ceará Fortaleza Brazil
| | - André Luis Menezes Carvalho
- Grupo de Inovação Tecnológicas e Especialidades Químicas (GRINTEQUI)Universidade Federal do Ceará Fortaleza Brazil
| | - Luciano Silva Lopes
- Laboratório de Pesquisa em Neuroquímica Experimental do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
| | | | | | - Ana Amélia Carvalho Melo‐Cavalcante
- Laboratório de Toxicidade Genética do Programa de Pós‐graduação em Ciências FarmacêuticasUniversidade Federal do Piauí Teresina Brazil
- Programa de Pós‐Graduação em Biotecnologia (RENORBIO)Universidade Federal do Piauí Teresina Brazil
| |
Collapse
|